GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Purchased by Marshall Wace LLP

Marshall Wace LLP lifted its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 22.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 240,713 shares of the company's stock after acquiring an additional 44,180 shares during the quarter. Marshall Wace LLP owned approximately 0.05% of GE HealthCare Technologies worth $18,819,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently made changes to their positions in GEHC. Cathy Pareto & Associates Inc. acquired a new position in shares of GE HealthCare Technologies in the 4th quarter worth approximately $670,000. Principal Financial Group Inc. lifted its position in shares of GE HealthCare Technologies by 1.9% in the third quarter. Principal Financial Group Inc. now owns 1,009,910 shares of the company's stock worth $94,780,000 after purchasing an additional 19,010 shares in the last quarter. Everence Capital Management Inc. increased its holdings in GE HealthCare Technologies by 118.2% during the fourth quarter. Everence Capital Management Inc. now owns 18,870 shares of the company's stock worth $1,475,000 after buying an additional 10,220 shares during the last quarter. Apollon Wealth Management LLC grew its holdings in GE HealthCare Technologies by 46.5% during the fourth quarter. Apollon Wealth Management LLC now owns 13,111 shares of the company's stock worth $1,025,000 after purchasing an additional 4,160 shares during the period. Finally, Sanibel Captiva Trust Company Inc. boosted its position in GE HealthCare Technologies by 139.9% during the fourth quarter. Sanibel Captiva Trust Company Inc. now owns 7,484 shares of the company's stock worth $585,000 after purchasing an additional 4,364 shares during the period. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Price Performance

Shares of GEHC traded up $1.39 during trading hours on Friday, reaching $68.44. 3,126,185 shares of the stock traded hands, compared to its average volume of 3,241,875. The company's 50-day moving average price is $77.07 and its two-hundred day moving average price is $82.34. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80. The company has a market cap of $31.33 billion, a P/E ratio of 15.80, a price-to-earnings-growth ratio of 3.19 and a beta of 1.14.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its quarterly earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating analysts' consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The firm had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. On average, analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Friday, April 25th will be issued a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, April 25th. This represents a $0.14 annualized dividend and a dividend yield of 0.20%. GE HealthCare Technologies's dividend payout ratio (DPR) is currently 3.23%.

Analyst Ratings Changes

Several research firms have commented on GEHC. The Goldman Sachs Group raised shares of GE HealthCare Technologies from a "neutral" rating to a "buy" rating and raised their target price for the company from $85.00 to $100.00 in a report on Tuesday, March 11th. Jefferies Financial Group raised shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and upped their price objective for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. BTIG Research set a $95.00 price target on GE HealthCare Technologies and gave the company a "buy" rating in a research note on Monday, April 14th. Citigroup raised their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a "buy" rating in a research note on Thursday, February 13th. Finally, Piper Sandler dropped their target price on GE HealthCare Technologies from $104.00 to $88.00 and set an "overweight" rating on the stock in a report on Wednesday. One investment analyst has rated the stock with a sell rating, two have given a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $96.50.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.